195 related articles for article (PubMed ID: 34893874)
1. NDRG1 in Aggressive Breast Cancer Progression and Brain Metastasis.
Villodre ES; Hu X; Eckhardt BL; Larson R; Huo L; Yoon EC; Gong Y; Song J; Liu S; Ueno NT; Krishnamurthy S; Pusch S; Tripathy D; Woodward WA; Debeb BG
J Natl Cancer Inst; 2022 Apr; 114(4):579-591. PubMed ID: 34893874
[TBL] [Abstract][Full Text] [Related]
2. NDRG1 regulates neutral lipid metabolism in breast cancer cells.
Sevinsky CJ; Khan F; Kokabee L; Darehshouri A; Maddipati KR; Conklin DS
Breast Cancer Res; 2018 Jun; 20(1):55. PubMed ID: 29898756
[TBL] [Abstract][Full Text] [Related]
3. NDRG1 deficiency is associated with regional metastasis in oral cancer by inducing epithelial-mesenchymal transition.
de Lima JM; Morand GB; Macedo CCS; Diesel L; Hier MP; Mlynarek A; Kowalski LP; Maschietto M; Alaoui-Jamali MA; da Silva SD
Carcinogenesis; 2020 Jul; 41(6):769-777. PubMed ID: 32112078
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.
Nagai MA; Gerhard R; Fregnani JH; Nonogaki S; Rierger RB; Netto MM; Soares FA
Breast Cancer Res Treat; 2011 Feb; 126(1):1-14. PubMed ID: 20369286
[TBL] [Abstract][Full Text] [Related]
5. The silencing of N-myc downstream-regulated gene-1 in an orthotopic pancreatic cancer model leads to more aggressive tumor growth and metastases.
Kim-Fuchs C; Winterhalder S; Winter A; Malinka T; Born D; Schäfer S; Stroka D; Gloor B; Candinas D; Angst E
Dig Surg; 2014; 31(2):135-42. PubMed ID: 24970329
[TBL] [Abstract][Full Text] [Related]
6. Association between NDRG1 protein expression and aggressive features of breast cancer: a systematic review and meta-analysis.
Kotepui K; Kotepui M; Majima HJ; Tangpong J
BMC Cancer; 2023 Oct; 23(1):1003. PubMed ID: 37858101
[TBL] [Abstract][Full Text] [Related]
7. N-myc downstream regulated gene-1 expression correlates with reduced pancreatic cancer growth and increased apoptosis in vitro and in vivo.
Angst E; Dawson DW; Stroka D; Gloor B; Park J; Candinas D; Reber HA; Hines OJ; Eibl G
Surgery; 2011 May; 149(5):614-24. PubMed ID: 21236457
[TBL] [Abstract][Full Text] [Related]
8. N-myc downstream-regulated gene 1 (NDRG1) a differentiation marker of human breast cancer.
Fotovati A; Abu-Ali S; Kage M; Shirouzu K; Yamana H; Kuwano M
Pathol Oncol Res; 2011 Sep; 17(3):525-33. PubMed ID: 21221878
[TBL] [Abstract][Full Text] [Related]
9. [Overexpression of NDRG1: relationship with proliferative activity and invasiveness of breast cancer cell line and breast cancer metastasis].
Wang Z; Liu Q; Chen Q; Zhu R; Zhu HG
Zhonghua Bing Li Xue Za Zhi; 2006 Jun; 35(6):333-8. PubMed ID: 16834906
[TBL] [Abstract][Full Text] [Related]
10. NDRG1 Expression Is an Independent Prognostic Factor in Inflammatory Breast Cancer.
Villodre ES; Gong Y; Hu X; Huo L; Yoon EC; Ueno NT; Woodward WA; Tripathy D; Song J; Debeb BG
Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33321961
[TBL] [Abstract][Full Text] [Related]
11. Aberrant NDRG1 methylation associated with its decreased expression and clinicopathological significance in breast cancer.
Han LL; Hou L; Zhou MJ; Ma ZL; Lin DL; Wu L; Ge YL
J Biomed Sci; 2013 Jul; 20(1):52. PubMed ID: 23899187
[TBL] [Abstract][Full Text] [Related]
12. Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma.
Hosoya N; Sakumoto M; Nakamura Y; Narisawa T; Bilim V; Motoyama T; Tomita Y; Kondo T
Biochim Biophys Acta; 2013 Dec; 1834(12):2630-9. PubMed ID: 23999030
[TBL] [Abstract][Full Text] [Related]
13. Expression of N-myc downstream-regulated gene 1 in primary gallbladder carcinoma and its correlation with clinicopathological features and clinical outcome.
Zhang SB; Song SP; Li B; Zhou YS; Zhang YD
Med Oncol; 2012 Sep; 29(3):1866-72. PubMed ID: 21735144
[TBL] [Abstract][Full Text] [Related]
14. Correlation of N-myc downstream-regulated gene 1 expression with clinical outcomes of colorectal cancer patients of different race/ethnicity.
Koshiji M; Kumamoto K; Morimura K; Utsumi Y; Aizawa M; Hoshino M; Ohki S; Takenoshita S; Costa M; Commes T; Piquemal D; Harris CC; Tchou-Wong KM
World J Gastroenterol; 2007 May; 13(20):2803-10. PubMed ID: 17569115
[TBL] [Abstract][Full Text] [Related]
15. Increased N-myc downstream-regulated gene 1 expression is associated with breast atypia-to-carcinoma progression.
Mao XY; Fan CF; Wei J; Liu C; Zheng HC; Yao F; Jin F
Tumour Biol; 2011 Dec; 32(6):1271-6. PubMed ID: 21909787
[TBL] [Abstract][Full Text] [Related]
16. TGFβ Governs the Pleiotropic Activity of NDRG1 in Triple-Negative Breast Cancer Progression.
López-Tejada A; Griñán-Lisón C; González-González A; Cara FE; Luque RJ; Rosa-Garrido C; Blaya-Cánovas JL; Navarro-Ocón A; Valenzuela-Torres M; Parra-López M; Calahorra J; Blancas I; Marchal JA; Granados-Principal S
Int J Biol Sci; 2023; 19(1):204-224. PubMed ID: 36594086
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma.
Chua MS; Sun H; Cheung ST; Mason V; Higgins J; Ross DT; Fan ST; So S
Mod Pathol; 2007 Jan; 20(1):76-83. PubMed ID: 17170744
[TBL] [Abstract][Full Text] [Related]
18. N-myc downstream-regulated gene 1 inhibits the proliferation of colorectal cancer through emulative antagonizing NEDD4-mediated ubiquitylation of p21.
Zhang S; Yu C; Yang X; Hong H; Lu J; Hu W; Hao X; Li S; Aikemu B; Yang G; He Z; Zhang L; Xue P; Cai Z; Ma J; Zang L; Feng B; Yuan F; Sun J; Zheng M
J Exp Clin Cancer Res; 2019 Dec; 38(1):490. PubMed ID: 31831018
[TBL] [Abstract][Full Text] [Related]
19. NDRG1 expression is related to the progression and prognosis of gastric cancer patients through modulating proliferation, invasion and cell cycle of gastric cancer cells.
Chang X; Xu X; Ma J; Xue X; Li Z; Deng P; Zhang S; Zhi Y; Chen J; Dai D
Mol Biol Rep; 2014 Sep; 41(9):6215-23. PubMed ID: 24985974
[TBL] [Abstract][Full Text] [Related]
20. Bidirectional Regulation between NDRG1 and GSK3β Controls Tumor Growth and Is Targeted by Differentiation Inducing Factor-1 in Glioblastoma.
Ito H; Watari K; Shibata T; Miyamoto T; Murakami Y; Nakahara Y; Izumi H; Wakimoto H; Kuwano M; Abe T; Ono M
Cancer Res; 2020 Jan; 80(2):234-248. PubMed ID: 31723002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
